![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1084, 2006-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety updates to US labelling for Avinza
Reactions Weekly, Vol. 1, Iss. 1077, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety updates to Zevalin labelling in the US
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety updates to Canadian labelling for Duragesic
Inpharma, Vol. 1, Iss. 1506, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Revised safety labelling for zanamivir in the US
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The US FDA has approved acetadote [acetylcysteine] labelling updates
Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. :